Total Payments
$11,360
2024 Payments
$5,206
Companies
58
Transactions
291
Medicare Patients
1,428
Medicare Billing
$123,595
Payment Breakdown by Category
Food & Beverage$5,589 (49.2%)
Consulting$3,483 (30.7%)
Other$1,193 (10.5%)
Education$1,096 (9.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,589 | 258 | 49.2% |
| Consulting Fee | $3,483 | 6 | 30.7% |
| Long term medical supply or device loan | $1,165 | 13 | 10.3% |
| Education | $1,096 | 12 | 9.6% |
| Debt forgiveness | $27.78 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,514 | 34 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,462 | 4 | $0 (2023) |
| Genentech USA, Inc. | $1,440 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $881.13 | 7 | $0 (2024) |
| ABBVIE INC. | $666.92 | 14 | $0 (2024) |
| Incyte Corporation | $599.19 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $574.97 | 20 | $0 (2024) |
| PFIZER INC. | $561.94 | 29 | $0 (2024) |
| GlaxoSmithKline, LLC. | $487.48 | 22 | $0 (2024) |
| Amgen Inc. | $334.01 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,206 | 117 | Genentech USA, Inc. ($1,423) |
| 2023 | $2,970 | 85 | Janssen Scientific Affairs, LLC ($562.50) |
| 2022 | $2,280 | 52 | Janssen Scientific Affairs, LLC ($899.17) |
| 2021 | $903.03 | 37 | Incyte Corporation ($203.36) |
All Payment Transactions
291 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug), TGCT | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 12/10/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Diabetes Care | ||||||
| 12/03/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 12/02/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: DESMOID TUMORS | ||||||
| 11/22/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $121.85 | General |
| Category: Hematology | ||||||
| 10/25/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Genentech USA, Inc. | Venclexta (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: BioOncology | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 10/17/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/15/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $23.04 | General |
| Category: Oncology / Rare Diseases | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ALUNBRIG (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.63 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 328 | 1,542 | $99,492 | $23,199 |
| 2022 | 4 | 367 | 705 | $161,699 | $34,185 |
| 2021 | 4 | 412 | 711 | $170,420 | $36,775 |
| 2020 | 5 | 321 | 558 | $126,359 | $29,436 |
Total Patients
1,428
Total Services
3,516
Medicare Billing
$123,595
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 207 | 327 | $78,480 | $18,453 | 23.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 22 | $7,546 | $1,845 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $4,719 | $1,239 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 12 | $2,964 | $810.36 | 27.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 46 | $3,312 | $492.66 | 14.9% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 12 | 1,050 | $1,801 | $281.11 | 15.6% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 33 | 72 | $670.05 | $79.20 | 11.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 240 | 493 | $117,840 | $24,977 | 21.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 78 | 122 | $40,817 | $8,621 | 21.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 18 | $2,322 | $489.56 | 21.1% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 36 | 72 | $720.00 | $97.03 | 13.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 253 | 485 | $116,400 | $25,656 | 22.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 110 | 144 | $49,392 | $10,090 | 20.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 22 | 32 | $4,128 | $951.32 | 23.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 27 | 50 | $500.00 | $77.90 | 15.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 222 | 430 | $103,200 | $23,540 | 22.8% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 49 | 74 | $9,546 | $2,255 | 23.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 23 | 24 | $8,215 | $1,903 | 23.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 15 | 18 | $2,445 | $1,041 | 42.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $2,953 | $697.02 | 23.6% |
About Kimberly Koval, RN, MSN, APN-C
Kimberly Koval, RN, MSN, APN-C is a Adult Health healthcare provider based in Springfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1083987101.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kimberly Koval, RN, MSN, APN-C has received a total of $11,360 in payments from pharmaceutical and medical device companies, with $5,206 received in 2024. These payments were reported across 291 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($5,589).
As a Medicare-enrolled provider, Koval has provided services to 1,428 Medicare beneficiaries, totaling 3,516 services with total Medicare billing of $123,595. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Adult Health
- Location Springfield, NJ
- Active Since 02/21/2012
- Last Updated 01/07/2020
- Taxonomy Code 363LA2200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083987101
Products in Payments
- Venclexta (Biological) $1,388
- KISQALI (Drug) $1,139
- VENCLEXTA (Drug) $652.48
- CALQUENCE (Drug) $555.15
- ERLEADA (Drug) $539.08
- DARZALEX (Biological) $438.00
- RYBREVANT (Drug) $375.00
- JAKAFI (Drug) $308.92
- LYNPARZA (Drug) $294.02
- MONOFERRIC (Drug) $289.11
- ZEJULA (Drug) $280.92
- KEYTRUDA (Biological) $264.75
- BRUKINSA (Drug) $177.76
- PADCEV (Biological) $141.31
- MONJUVI (Drug) $136.38
- JEMPERLI (Biological) $135.60
- Stivarga (Drug) $131.37
- LUMAKRAS (Drug) $129.10
- OXBRYTA (Drug) $122.50
- REBLOZYL (Biological) $121.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Springfield
Andrea Bushnell, Agnp-C, AGNP-C
Adult Health — Payments: $12,450
Adult Health $12,450
Heidi Crull, Anp-Bc, ANP-BC
Adult Health — Payments: $7,347
Adult Health $7,347
Mrs. Jennifer Chieppa, Np-C, NP-C
Adult Health — Payments: $4,961
Adult Health $4,961
Marlene Schmitz
Adult Health — Payments: $3,503
Adult Health $3,503
Marcy Bot-Baron, Anp, ANP
Adult Health — Payments: $3,493
Adult Health $3,493
Mrs. Brittney Veenstra, Anp, ANP
Adult Health — Payments: $3,084
Adult Health $3,084